Pharmacology Research - Pharmacogenomics, Drug Development, New Medications

Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.


Pharmacology Research Today

Home

View Latest Issue

Information About Pharmacology

Books on Pharmacology

Advertising in Research Today

View Other Research Today Publications



A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicals.

Matthews EJ, Kruhlak NL, Daniel Benz R, Ivanov J, Klopman G, Contrera JF

US Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, USA. edwin.matthews@fda.hhs.gov <edwin.matthews@fda.hhs.gov>

This report describes the construction, optimization and validation of a battery of quantitative structure-activity relationship (QSAR) models to predict reproductive and developmental (reprotox) hazards of untested chemicals. These models run with MC4PC software to predict seven general reprotox classes: male and female reproductive toxicity, fetal dysmorphogenesis, functional toxicity, mortality, growth, and newborn behavioral toxicity. The reprotox QSARs incorporate a weight of evidence paradigm using rats, mice, and rabbit reprotox study data and are designed to identify trans-species reprotoxicants. The majority of the reprotox QSARs exhibit good predictive performance properties: high specificity (>80%), low false positives (<20%), significant receiver operating characteristic (ROC) values (>2.00), and high coverage (>80%) in 10% leave-many-out validation experiments. The QSARs are based on 627-2023 chemicals and exhibited a wide applicability domain for FDA regulated organic chemicals for which they were designed. Experiments were also performed using the MC4PC multiple module prediction technology, and ROC statistics, and adjustments to the ratio of active to inactive (A/I ratio) chemicals in training data sets were made to optimize the predictive performance of QSAR models. Results revealed that an A/I ratio of approximately 40% was optimal for MC4PC. We discuss specific recommendations for the application of the reprotox QSAR battery.

Published 12 February 2007 in Regul Toxicol Pharmacol, 47(2): 136-55.
Full-text of this article is available online (may require subscription).

Place a permanent text-link or advertisement here for just US$15.

© 2005-2008 Pharmacology Research Today. All Rights Reserved.



Pharmacology Research Today Archive:

Volume 1 (2005)
  Issue 1 (August)
  Issue 2 (September)
  Issue 3 (October)
  Issue 4 (November)
  Issue 5 (December)

Volume 2 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)



Pharmacology Books

The 24-Hour Pharmacist: Advice, Options, and Amazing Cures from America's Most Trusted Pharmacist

The 24-Hour Pharmacist: Advice, Options, and Amazing Cures from America's Most Trusted Pharmacist